MAPT and Alzheimer disease: Specifically, hyperforin has been shown to reduce β-amyloid production and Tau phosphorylation in PC12 cells, while exerting anti-apoptotic, anti-inflammatory, and antioxidant effects in mouse models of AD [134,135,136].